U. Maharoof

发表

6-Substituted quinolines as RORγt inverse agonists.

J. Edwards, J. Spurlino, M. Cummings, 2017, Bioorganic & medicinal chemistry letters.

Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt.

J. Edwards, J. Spurlino, M. Cummings, 2017, Bioorganic & medicinal chemistry letters.

(6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells.

Jian Li, Judith Baker, Hong-tao Lu, 2005, Journal of medicinal chemistry.

Studies on the narciclasine alkaloids: Total synthesis of (+)- narciclasine and (+)-pancratistatin

J. H. Rigby, U. Maharoof, Mary E. Mateo, 2000 .

Diverging stereochemical pathways in an intramolecular Diels-Alder reaction determined by dienophile structure.

G. Sulikowski, Kwangho Kim, Jessica Raushel, 2003, Organic letters.

Investigations into arylquinone atropisomers: synthesis and evaluation

G. Sulikowski, U. Maharoof, 2003 .

Investigations into Arylquinone Atropisomers: Synthesis and Evaluation.

G. Sulikowski, U. Maharoof, 2004 .

A Negative Activation Energy for Luminescence Decay: Specific Solvation Effects on the Emission Properties of Bis(2,2‘-bipyridine)(3,5-dicarboxy-2,2‘-bipyridine)ruthenium(II) Chloride

K. Deshayes, M. Y. Ogawa, T. Kinstle, 1996 .

EPS3.10 Novel CFTR modulator combinations directly address the ΔF508-CFTR NBD1 stability defect and enable full CFTR correction

G. Hurlbut, S. Bercury, D. Stepp, 2023, Journal of Cystic Fibrosis.